A Look At FactSet Research Systems (FDS) Valuation After Recent Share Price Weakness

فاكتست لنظم البحوث +1.25%

FactSet Research Systems Inc.

FDS

227.68

+1.25%

FactSet Research Systems overview after recent price moves

FactSet Research Systems (FDS) has drawn attention after a recent pullback, with the stock down about 3% over the past day and 8.8% over the past week, while its past month return is slightly positive.

Over the past 3 months, the share price shows a 29.5% decline and the 1 year total return is down about 51.5%. This has prompted some investors to reassess how current pricing lines up with FactSet’s fundamentals and value score.

With the share price now at about US$205.54, FactSet’s recent 1 day and 7 day share price declines sit against a much weaker 1 year total shareholder return. This suggests that momentum has faded as investors reassess growth prospects and risk.

If this shift in sentiment has you looking beyond a single name, it could be a good moment to broaden your watchlist with 20 top founder-led companies as potential long term compounders.

With FactSet trading around US$205.54, well below analyst targets and with a value score of 5, the key question is whether this signals genuine undervaluation or if the market is already pricing in future growth.

Most Popular Narrative: 34.5% Undervalued

According to a widely followed narrative by SelectiveCapital, FactSet’s fair value of about $313.99 sits well above the last close at $205.54. This points to a sizeable valuation gap that hinges on how investors see the business today versus what it could become.

At the current price of ~210 USD, the market is valuing FactSet as a certain victim of generative AI (“SaaSPocalypse”), completely ignoring the company’s structural transformation over the last 5 years. FactSet no longer sells just access to stock prices (which can be commoditized); it sells operational infrastructure built on four strategic pillars that are extremely hard for a chatbot to replace: Cobalt (Private Markets), CUSIP (Global Standards), Vermilion (Reporting), and Portware (Execution).

Curious what supports a higher fair value than the current share price? This narrative leans on compound revenue growth, firm margins, and a future earnings multiple that looks very different from today. The full story connects those inputs into one cohesive valuation argument.

Result: Fair Value of $313.99 (UNDERVALUED)

However, this hinges on CUSIP, Cobalt, Vermilion, and Portware continuing to hold their roles, and on AI or rival platforms not compressing pricing power faster than expected.

Next Steps

If this mix of concern and optimism feels familiar, now is a good time to look through the numbers yourself and decide what really matters for you as an investor. You can start with 5 key rewards and 1 important warning sign.

Looking for more investment ideas?

If this FactSet story has sharpened your thinking, do not stop here. Broaden your opportunity set with focused stock lists that match your style.

  • Target potential mispricings by scanning 50 high quality undervalued stocks, which pairs solid fundamentals with prices that may not fully reflect those qualities.
  • Prioritize resilience and sleep better at night by checking 67 resilient stocks with low risk scores, built around businesses with lower overall risk profiles.
  • Hunt for lesser known potential opportunities through screener containing 23 high quality undiscovered gems, which many investors may not yet be watching closely.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.